Found: 16
Select item for more details and to access through your institution.
Biological therapy practice, biomarkers of severe asthma and novel approaches for attaining immunomodulation in upper airway disease.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 130, doi. 10.1111/cea.14292
- By:
- Publication type:
- Article
Ultrasound‐guided intralymphatic immunotherapy: A single‐center trial of a clinical skills training programme.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 244, doi. 10.1111/cea.14280
- By:
- Publication type:
- Article
Biomarkers in tear fluid of dupilumab‐treated moderate‐to‐severe atopic dermatitis patients.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 239, doi. 10.1111/cea.14269
- By:
- Publication type:
- Article
Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study).
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 233, doi. 10.1111/cea.14267
- By:
- Publication type:
- Article
The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 156, doi. 10.1111/cea.14263
- By:
- Publication type:
- Article
From trained immunity in allergy to trained immunity‐based allergen vaccines.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 145, doi. 10.1111/cea.14261
- By:
- Publication type:
- Article
Intestinal epithelial cell barrier dysfunction and elevated Angiopoietin‐like 4 identified in orally susceptible peanut allergy model.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 210, doi. 10.1111/cea.14248
- By:
- Publication type:
- Article
In vitro detection of T cell sensitization by interferon–γ secretion in immediate‐type drug allergy.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 222, doi. 10.1111/cea.14253
- By:
- Publication type:
- Article
Change in total IgE levels in inner city patients receiving monoclonal biological agents for allergic disorders.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 230, doi. 10.1111/cea.14259
- By:
- Publication type:
- Article
Dual GIPR and GLP‐1R agonist tirzepatide inhibits aeroallergen‐induced allergic airway inflammation in mouse model of obese asthma.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 216, doi. 10.1111/cea.14252
- By:
- Publication type:
- Article
House dust mite components sensitization profile in China, a multi‐centre study.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 226, doi. 10.1111/cea.14255
- By:
- Publication type:
- Article
Landscape of short‐acting beta‐agonists (SABA) overuse in Europe.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 132, doi. 10.1111/cea.14250
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 127, doi. 10.1111/cea.14161
- Publication type:
- Article
Recombinant T‐cell epitope conjugation: A new approach for Dermatophagoides hypoallergen design.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 198, doi. 10.1111/cea.14238
- By:
- Publication type:
- Article
Exploring proteomic plasma biomarkers in eosinophilic and neutrophilic asthma.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 186, doi. 10.1111/cea.14229
- By:
- Publication type:
- Article
Biologic therapy practices in severe asthma; outcomes from the UK Severe Asthma Registry and survey of specialist opinion.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 173, doi. 10.1111/cea.14222
- By:
- Publication type:
- Article